Last reviewed · How we verify
NCT06634238
Acute Mask Effects on Walk Distance and Vital Signs
trial testing Incremental shuttle walk test in Mask Usage Condition in 30 participants. Not yet recruiting.
15 February 2025
Quick facts
| Lead sponsor | Nagihan Acet |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 15 October 2024 |
| Primary completion | 15 February 2025 |
| Estimated completion | 1 March 2025 |
Drugs / interventions tested
- Incremental shuttle walk test
Conditions studied
- Mask Usage Condition — all drugs for Mask Usage Condition →
Sponsor
Nagihan Acet
Who can join
Adults 18 to 24, any sex, with Mask Usage Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this prospective observational study is to investigate the acute effects of mask use on walking distance and vital signs in healthy individuals aged 18-24 years. The main questions it aims to answer are: Does wearing a mask affect walking distance during the Incremental Shuttle Walk Test (ISWT)? How does mask use influence heart rate, oxygen saturation, blood pressure, and respiratory rate during the test? Researchers will compare participants performing the ISWT with a mask to those performing it without a mask to determine any differences in walking distance and vital signs. Participants will: Complete the ISWT twice: once with a mask and once without a mask, on separate days. Have their heart rate, oxygen saturation, respiratory rate, blood pressure, and dyspnea perception measured before and after each test.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06634238
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Incremental shuttle walk test
Trials testing the same drug.
- NCT04864132 — The Investigation Of Exercise Capacity And Exercise-Induced Fatigue in Young Adults Who Survived From Coronavirus · completed
- NCT04086953 — Validation of a Walk-Time Limit Test (WTLT) Derived from the 6-Minute Walk Test (6-MWT) in Patients with Chronic Cardiov · NA · terminated
- NCT03410498 — The Effects of FES in a Variety of Walking Conditions in People With MS · NA · unknown
- NCT04440124 — Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing E · completed
Other Nagihan Acet trials
Trials by the same sponsor.
- NCT06689319 — Factors Linked to AI Literacy in University Students · completed
- NCT06603493 — Headaches: Effects on Sleep, Sensitization, and Psychological Factors · completed
- NCT06598774 — Cervical Parameters and Body Awareness in Relation to Smartphone Addiction · completed
- NCT06559397 — Proprioceptive Puzzle: Effects on Quantitative Sensory Tests and Body Awareness · completed
- NCT06558318 — TMJ Dysfunction: Effects on Proprioception, Pain, and Body Awareness · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06634238 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nagihan Acet
- Last refreshed: 15 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06634238.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing